Zobrazeno 1 - 10
of 26
pro vyhledávání: '"O O Znoĭko"'
Autor:
N D Yushchuk, E A Klimova, O O Znoyko, M M Gadzhikulieva, E N Il'ina, T L Yashina, N A Malyshev, E V Tsyganova, N D Yuschuk, O O Znoiko, E N Ilyina
Publikováno v:
Терапевтический архив, Vol 81, Iss 4, Pp 47-54 (2009)
Aim. To evaluate HCV genome variability in acute and chronic phases of viral hepatitis C. Material and methods. The study of heterogeneity of HCV in acute hepatitis C has detected genetic heterogeneity and variability of individual HCV population cir
Externí odkaz:
https://doaj.org/article/d0682e6ebd4548d3b1243413363067f5
Publikováno v:
Терапевтический архив, Vol 86, Iss 10, Pp 77-81 (2014)
The incidence of chronic viral hepatitides (CVH) has increased 2.2-fold in the Russian Federation over the past decade. This increase is mainly determined by an almost threefold rise in the incidence of chronic hepatitis C (CHC): from 12.9 in 1999 to
Externí odkaz:
https://doaj.org/article/a908ff40e99d458aa5827dd28a564765
Autor:
N D Iushchuk, O O Znoĭko, N A Iakushechkina, S K Zyrianov, S A Shut'ko, P A Belyĭ, A N Kozina, S A Chapurin, Iu Iu Churilin, E A Lugovskikh
Publikováno v:
Терапевтический архив, Vol 85, Iss 12, Pp 79-85 (2013)
AIM: To evaluate the impact of using the innovative antiviral drugs in patients with chronic hepatitis C (CHC) on the disease burden in the long term. Materials and methods. A program was developed to increase the availability of innovative antiviral
Externí odkaz:
https://doaj.org/article/e39ba430426e48ccabd1c939d02b9d88
Autor:
N D Iushchuk, O O Znoĭko, I P Balmasova, N V Fedoseeva, E V Shmeleva, K R Dudina, E A Klimova, T V Petrova, D Iu Trofimov, P A Belyĭ, N Kh Safiullina, E V Pypkina
Publikováno v:
Терапевтический архив, Vol 84, Iss 11, Pp 11-17 (2012)
Aim. To determine the correlation between interleukin 28B (IL28B) gene polymorphism in patients with chronic hepatitis C (CHC), the presence or absence a rapid virologic response to antiviral therapy, and a number of immunological characteristics as
Externí odkaz:
https://doaj.org/article/653a5ea1b04941b889cca3faad59438e
Publikováno v:
Терапевтический архив, Vol 84, Iss 11, Pp 61-63 (2012)
The paper gives concise data on the efficacy of entecavir in the treatment of chronic hepatitis B caused by its resistant virus strain and describes a relevant clinical case.
Externí odkaz:
https://doaj.org/article/0827987c70a44c6880672110f8c36005
Autor:
N D, Iushchuk, O O, Znoĭko, N A, Iakushechkina, S K, Zyrianov, S A, Shut'ko, P A, Belyĭ, A N, Kozina, S A, Chapurin, Iu Iu, Churilin, E A, Lugovskikh
Publikováno v:
Terapevticheskii arkhiv. 85(12)
To evaluate the impact of using the innovative antiviral drugs in patients with chronic hepatitis C (CHC) on the disease burden in the long term.A program was developed to increase the availability of innovative antiviral therapy (AVT) in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::540d57ba8d13b80e0ec093d79968c613
https://pubmed.ncbi.nlm.nih.gov/24640674
https://pubmed.ncbi.nlm.nih.gov/24640674
Autor:
N V, Fedoseeva, E V, Shmeleva, O S, Kapitonova, I P, Balmasova, M M, Gul'tiaev, O O, Znoĭko, N D, Iushchuk
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (3)
Evaluation of CD3+ and CD3-/CD56+ proliferative response on hepatitis C virus antigens in healthy medical workers.The study included 15 medical workers with length of service of 2 and more years without common risk factors (blood and blood products t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92e9dd458e893ee10b7ac6e35c2715b5
https://pubmed.ncbi.nlm.nih.gov/24000592
https://pubmed.ncbi.nlm.nih.gov/24000592
Autor:
K R, Dudina, O O, Znoĭko, Iu G, Trubitsyna, S A, Shut'ko, V N, Kuz'min, A G, Serobian, N R, Revazian, T V, Petrova, N P, Blokhina, N D, Iushchuk
Publikováno v:
Terapevticheskii arkhiv. 82(11)
to define a role of hepatotropic (HAV, HBV, HCV, and HDV) and opportunistic hepatotropic (HGV, CMV, EBV, HHV types 1, 2, and 6) viruses in the etiological pattern of diseases accompanied by enhanced blood AlAT and AsA T activities in pregnant women.T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a79aee663ae9a7c51d74d761f5ee631
https://pubmed.ncbi.nlm.nih.gov/21381349
https://pubmed.ncbi.nlm.nih.gov/21381349
Autor:
K R, Dudina, S A, Shut'ko, O O, Znoĭko, E A, Klimova, Iu G, Trubitsyna, L E, Kuzina, S N, Kuzin, D N, Braginskiĭ, V I, Kashirin, D S, Cheshik, A G, Serobian, T V, Penkina, I B, Korshunov, E S, V'iuchnova, N D, Iushchuk
Publikováno v:
Terapevticheskii arkhiv. 80(11)
To estimate HbsAg in patients with different variants of chronic HBV infection.Assay of HbsAg (IU/ml) in blood serum was made in 156 patients with chronic HBV infection (70 males and 86 females, age 19 to 78 years) using the test-system HbsAg Archite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::012c986305c8ea939ca450879c67a4d5
https://pubmed.ncbi.nlm.nih.gov/19143186
https://pubmed.ncbi.nlm.nih.gov/19143186
Publikováno v:
Voprosy virusologii. 53(2)
The condition of the host at the moment of infection is that its immune competence largely determines the efficiency, kinetics, and profile (Thl/Th2) of a further specific immunity response and, accordingly, the outcome of penetration of hepatitis C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46f3f4fa7b8c5cba3a9427db20a6cca6
https://pubmed.ncbi.nlm.nih.gov/18450102
https://pubmed.ncbi.nlm.nih.gov/18450102